Confluence Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Confluence Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$707K	Sell	2,601 -317	-11%	-$117K	0.35%	68
2020 Q2	$963K	Buy	2,918 +235	+9%	+$68K	0.45%	55
2020 Q1	$650K	Buy	2,683 +46	+2%	+$12K	0.36%	62
2019 Q4	$689K	Buy	2,637 +36	+1%	+$9.49K	0.32%	70
2019 Q3	$707K	Sell	2,601 -9	-0.3%	-$2.5K	0.35%	68
2019 Q2	$719K	Sell	2,610 -34	-1%	-$8.38K	0.35%	68
2019 Q1	$591K	Buy	2,644 +53	+2%	+$10.9K	0.29%	73
2018 Q4	$482K	Sell	2,591 -96	-4%	-$19.7K	0.27%	77
2018 Q3	$671K	Sell	2,687 -20	-0.7%	-$4.86K	0.35%	67
2018 Q2	$590K	Buy	2,707 +145	+6%	+$29.9K	0.31%	71
2018 Q1	$490K	Buy	+2,562	New	+$473K	0.25%	77

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Confluence Wealth Management's IDXX Position: Q3 2020 in Review

Confluence Wealth Management reduced its Idexx Laboratories (IDXX) stake by 11% in Q3 2020, selling an estimated $117K and leaving 2,601 shares worth $707K. The position accounts for 0.35% of the portfolio, ranked #68.

Confluence Wealth Management first reported a position in IDXX in Q1 2018 and has held it in 11 quarters since. The position peaked at $963K in Q2 2020. 846 funds tracked by Wall St. Rank hold IDXX as of Q3 2020.

Confluence Wealth Management held 2,601 shares of Idexx Laboratories worth $707K as of Q3 2020.
Confluence Wealth Management sold 317 Idexx Laboratories shares in Q3 2020, an estimated $117K.
Idexx Laboratories made up 0.35% of Confluence Wealth Management's portfolio in Q3 2020, its #68 holding.
Confluence Wealth Management first reported a position in Idexx Laboratories in Q1 2018 and has held it in 11 quarters since.
Confluence Wealth Management's Idexx Laboratories position peaked at $963K in Q2 2020.
846 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2020.

Based on Confluence Wealth Management's 13F filing for Q3 2020, filed 26 Oct 2020.